… to improve invasive breast cancer free survival meets … to prevent metastatic breast cancer recurrence in the … patients with HER2-positive breast cancer following surgery, according … neoadjuvant and postoperative adjuvant Herceptin (trastuzumab)-based treatment …

… positive, HER2-positive breast cancer who have completed … breast cancer following surgery and 12 months of adjuvant trastuzumab (Herceptin … to prevent metastatic breast cancer recurrence in the … GP2 vaccine in breast cancer patients to prevent recurrence …

… and adjuvant trastuzumab (Herceptin)-based standard-of-care breast cancer therapy, have an … evidence of residual or persistent breast cancer per treating physician assessment. … IV or metastatic breast cancer at any time, inflammatory breast cancer, a history …

… II or III HER2-positive breast cancer. Findings from CompassHER2 pCR presented … paclitaxel or docetaxel, plus trastuzumab (Herceptin) and pertuzumab (Perjeta; THP), without …

… with a taxane with trastuzumab (Herceptin) and pertuzumab (Perjeta; THP) in … II to IIIA HER2-positive breast cancer who have no cancer remaining …

… HR-positive metastatic breast cancer that are HER2 … breast cancer related death.  HER2 interpretation in breast cancer … positive, HER2-negative breast cancer patients may be considered … breast cancer patients eligible for HER2-targeted treatment with Herceptin …

… metastatic breast cancer previously treated with trastuzumab (Herceptin) and … tumors, or contralateral breast cancer. Patients with uncontrolled … [patients with] breast cancer. Together with our … metastatic or unresectable breast cancer. News release. …

… is approved for metastatic breast cancer and as an neoadjuvant treatment … to Kadcyla’s global breast cancer sales of nearly US$ … , Duality Biologics recruited 228 breast cancer patients who had previously received … anti-HER2 antibody trastuzumab (Herceptin).

… positive breast cancer who have previously been treated with trastuzumab (Herceptin) and … with HER2-low metastatic breast cancer. This additional trial underscores … HER2-Positive Metastatic or Unresectable Breast Cancer. News release. BioNTech. September …

… has reported a breakthrough in breast cancer treatment, with its experimental drug … after prior chemotherapy and trastuzumab (Herceptin). BioNTech said patients on the …